E
INmune Bio, Inc. INMB
$1.98 -$0.03-1.49% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- 50.00K 0.00 -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- 50.00K 0.00 -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- 50.00K 0.00 -- --
SG&A Expenses 2.25M 2.32M 2.11M 2.22M 2.81M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 8.06M 9.96M 9.47M 12.29M 9.87M
Operating Income -8.06M -9.91M -9.47M -12.29M -9.87M
Income Before Tax -24.46M -9.74M -9.22M -12.09M -9.75M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -24.46M -9.74M -9.22M -12.09M -9.75M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -24.46M -9.74M -9.22M -12.09M -9.75M
EBIT -8.06M -9.91M -9.47M -12.29M -9.87M
EBITDA -- -- -- -- --
EPS Basic -1.05 -0.43 -0.41 -0.60 -0.50
Normalized Basic EPS -0.21 -0.27 -0.26 -0.37 -0.32
EPS Diluted -1.05 -0.43 -0.41 -0.60 -0.50
Normalized Diluted EPS -0.21 -0.27 -0.26 -0.37 -0.32
Average Basic Shares Outstanding 23.30M 22.50M 22.25M 20.19M 19.31M
Average Diluted Shares Outstanding 23.30M 22.50M 22.25M 20.19M 19.31M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --